Mazdutide
(IBI362) Mazdutide is the world’s first dual GLP-1 receptor and glucagon receptor agonist, approved in China (June 2025) for chronic weight management. This once-weekly injectable leverages synergistic metabolic effects by: GLP-1 receptor activation - glucosedependent insulin secretion, appetite suppression. Glucagon receptor activation increased energy expenditure. Pharmacokinetics Extended half-life: 174–1075 hours via fatty acid conjugation and albumin binding. Allows once-weekly dosing.
SKU PC-MAZD-5Request this size
1 vial+35% margin
$45.003-month (3 vials)+25% margin
$124.99Bulk (10 vials)+15% margin
$383.29Published cost per vial$33.33
No cart yet. Email us the SKU and size you want — we invoice from the published price above.
How this price is built
Sourcing & raw material$20.66
Third-party lab verification$7.67
Cold-chain packaging & shipping$5.00
Cost per vial$33.33